An Intervention to Protect Young Children From Tobacco Smoke Exposure
NCT ID: NCT02867241
Last Updated: 2018-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
160 participants
INTERVENTIONAL
2016-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Program to Protect Young Children From Tobacco Smoke Exposure
NCT01335178
Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants
NCT00757224
Anti-Smoking Program for Parents: Effects on Child Smoking
NCT00056927
Effects of Parent-child Interactive Intervention in Preventing Children's Environmental Tobacco Smoke Exposure at Home
NCT02440321
PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children
NCT00135213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This RCT is a continuation of previous work. Originally the entire research project, which included a Pilot Study and a Randomized Controlled Trial (RCT) was registered as NCT01335178. Upon completion of the Pilot Study, we closed NCT01335178 and opened a new one for the RCT with the current registration number.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
1. Motivational interviews (3 visits) + supportive phone calls
2. Feedback of child hair nicotine levels
3. Feedback of home air quality (PM2.5)
4. New Media (Website and/or Facebook with information and parental forum)
Behavioral Early
Participants will receive an intervention which includes motivational interviewing, biochemical feedback, air quality feedback, phone calls, and social media
Control Regular
This group will get no intervention during the study period. Following the close of the study, participants in this group will receive a shortened version of the intervention (1 motivational interview, with feedback on child hair nicotine levels and feedback on home air quality (PM2.5))
Behavioral Late
After the close of the study, Participants will receive an intervention which includes motivational interviewing, biochemical feedback, air quality feedback, phone calls, and social media
Control Expanded
This group will get no intervention during the study period. However, participants will fill out a detailed questionnaire on parental perceptions of exposure and risk, as well as questions on social norms, self-efficacy, and knowledge Following the close of the study, participants in this group will receive a shortened version of the intervention (1 motivational interview, with feedback on child hair nicotine levels and feedback on home air quality (PM2.5))
Behavioral Late
After the close of the study, Participants will receive an intervention which includes motivational interviewing, biochemical feedback, air quality feedback, phone calls, and social media
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Early
Participants will receive an intervention which includes motivational interviewing, biochemical feedback, air quality feedback, phone calls, and social media
Behavioral Late
After the close of the study, Participants will receive an intervention which includes motivational interviewing, biochemical feedback, air quality feedback, phone calls, and social media
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. \- Parents willing to provide child hair samples
3. \- Hebrew speaking participants
4. \- Parents are willing to participate from time of entry for the coming 8 months .
Exclusion Criteria
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Flight Attendant Medical Research Institute (FAMRI)
UNKNOWN
Hebrew University
UNKNOWN
Assaf-Harofeh Medical Center
OTHER_GOV
Tel Aviv University
OTHER
Laura J. Rosen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura J. Rosen
Senior Lecturer and Chair, Dept. of Health Promotion
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura J Rosen, PhD
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv University
David M Zucker, PhD
Role: STUDY_DIRECTOR
Hebrew University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv University
Ramat Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rosen L, Zucker D, Guttman N, Brown N, Bitan M, Rule A, Berkovitch M, Myers V. Protecting Children From Tobacco Smoke Exposure: A Randomized Controlled Trial of Project Zero Exposure. Nicotine Tob Res. 2021 Nov 5;23(12):2003-2012. doi: 10.1093/ntr/ntab106.
Myers V, Shiloh S, Zucker DM, Rosen LJ. Changing Exposure Perceptions: A Randomized Controlled Trial of an Intervention with Smoking Parents. Int J Environ Res Public Health. 2020 May 12;17(10):3349. doi: 10.3390/ijerph17103349.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0143-16ASF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.